|
|
 |
|
|
|
|
|
A 26-year-old man with ocular complications after adverse reaction to phenytoin
Digital Journal of Ophthalmology 2016
Volume 22, Number 4
October 4, 2016
DOI: 10.5693/djo.03.2015.05.002
|
Printer Friendly
Download PDF |
|
|
Ritesh Gupta, MD | Faculty of Medicine, University of Toronto, Toronto, Canada Vasudha Gupta, MD, FRCSC | Department of Ophthalmology, McMaster University, Hamilton, Ontario, Canada Yasser Khan, MD, FRCSC | Faculty of Medicine, University of Toronto, Toronto, Canada Department of Ophthalmology, McMaster University, Hamilton, Ontario, Canada
|
|
|
| References | 1. Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000;115:149-53.
2. Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea 2007;26:123-9.
3. De Rojas MV, Dart JKG, Saw VPJ. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. Br J Ophthalmol 91;2007:1048-53.
4. Morales ME, Purdue GF, Verity SM, Arnoldo BD, Blomquist PH. Ophthalmic manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis and relation to SCORTEN. Am J Ophthalmol 2010;150:505-10.e1.
5. Fu Y, Gregory DG, Sippel KC, Bouchard CS, Tseng SCG. The ophthalmologist’s role in the management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis. Ocul Surf 2010;8:193-203.
6. Sotozono C, Ueta M, Koizumi N, et al. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology 2009;116:685-90.
7. Tomlins PJ, Parulekar MV, Rauz S. “Triple-TEN” in the treatment of acute ocular complications from toxic epidermal necrolysis. Cornea 2013;32:365-9. | |
|
|
|
|
|
|
Welcome, please sign in 
